ABN AMRO Bank’s Cardinal Health CAH Stock Holding History

ABN AMRO Bank’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.34M	Buy	14,130 +2,525	+22%	+$525K	0.04%	130
2026 Q1	$2.43M	Buy	+11,605	New	+$2.5M	0.03%	133

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

ABN AMRO Bank's CAH Position: Q2 2026 in Review

ABN AMRO Bank increased its Cardinal Health (CAH) stake by 22% in Q2 2026, buying an estimated $525K and bringing the position to 14,130 shares worth $3.34M. The position accounts for 0.04% of the portfolio, ranked #130.

ABN AMRO Bank first reported a position in CAH in Q1 2026 and has held it in 2 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

ABN AMRO Bank held 14,130 shares of Cardinal Health worth $3.34M as of Q2 2026.
ABN AMRO Bank bought 2,525 Cardinal Health shares in Q2 2026, an estimated $525K.
Cardinal Health made up 0.04% of ABN AMRO Bank's portfolio in Q2 2026, its #130 holding.
ABN AMRO Bank first reported a position in Cardinal Health in Q1 2026 and has held it in 2 quarters since.
1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.